NCATS inks drug-screening partnership with Lilly
The drug company Eli Lilly will screen more than 3,800 approved and investigational medicines to find potential new uses for the drugs in a partnership with the US National Center for Advancing Translational Sciences (NCATS). Read more
Recent comments on this blog
Experiments reveal that crabs and lobsters feel pain
US research ethics agency upholds decision on informed consent
Chemistry credit disputes under the spotlight
Chemistry credit disputes under the spotlight
Contamination created controversial ‘acid-induced’ stem cells